BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Advanced Bio Surfaces Receives FDA Clearance To Market For OrthoGlide(R) Medial Knee Implant


2/8/2006 1:00:39 PM

MINNEAPOLIS, Feb. 8 /PRNewswire/ -- Advanced Bio-Surfaces, Inc. (ABS) an orthopedic implant developer and manufacturer, announced today it has received 510(k) clearance to market from the U.S. Food and Drug Administration (FDA) for its OrthoGlide Medial Knee Implant.

The OrthoGlide implant is an innovative design composed of cobalt-chrome alloy intended to replace some of the cartilage functions that have been lost due to osteoarthritis. The implant's unique engineering design provides positional stability without the use of rigid fixation methods. In addition, the specially contoured geometry of the implant provides an open glide path, allowing for the unconstrained motion of the femoral condyle.

"Advanced Bio-Surfaces is excited to expand the surgical treatment options currently available to patients with osteoarthritis. We believe the OrthoGlide Medial Knee Implant may be a better choice for patients facing more invasive treatments, which usually require extensive tissue and bone removal," said Dr. Jeff Felt, Chairman and CEO of Advanced Bio-Surfaces. Dr. Felt continued, "From a technology standpoint this has been an underserved area of orthopedics. The introduction of OrthoGlide represents an excellent opportunity for ABS to capture a significant section of this expanding market."

Dr. David Raab, practicing orthopedic surgeon at Illinois Bone and Joint Institute said, "The OrthoGlide implant was designed and developed using input from multiple orthopedic surgeons." Dr Raab went on to say, "I'm pleased to participate in a post-market clinical study supported by ABS. Data will be collected on OrthoGlide's ability to reduce patient pain and increase knee function through a minimally invasive procedure."

About Advanced Bio-Surfaces, Inc.

ABS is a privately held company dedicated to the development of innovative joint repair products. The company's first product, the OrthoGlide Medial Knee Implant, is intended for treatment of patients with moderate osteoarthritis of the medial compartment. For additional information contact Robert Siegfried at 952.912.5400.

Advanced Bio-Surfaces, Inc.

CONTACT: Robert Siegfried, VP, Finance and Administration of AdvancedBio-Surfaces, Inc., +1-952-912-5400



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES